India, Feb. 28 -- BioXcel Therapeutics, Inc. (BTAI) is up 32.91 percent, rising $0.97 to trade at $2.30 after the company announced it has regained compliance with the Nasdaq minimum closing bid price requirement.
The stock opened at $1.95 and has traded between $1.82 and $2.82 today on the Nasdaq. Trading volume has skyrocketed to 80.19 million shares, far exceeding its average of 147,006.
BioXcel's 52-week range is $1.72 to $52.80.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....